More Business Wire
View Older Stories View Newer Stories-
FINEOS and Osara Health Partner to Enhance Cancer Care
-
Atom Bioscience Raises $83M in a D-Round Financing to Support Global Pivotal Clinical Trials of ABP-671, a New Treatment for Chronic Gout
-
Enchant Agency & Four Seasons Health Care Group Shortlisted for Klaviyo’s The Klicks Awards in Advanced Email Marketing Automation
-
Holiday Ecommerce Sales Growth Won’t Be Enough to Top European Inflation, Study Says
-
dynaCERT Launches $6,000,000 Non-Brokered Private Placement of Equity
-
Veritonic Revolutionizes Advertising Insights with Brand Lift Measurement for Baked-In Audio Ads
-
Former Vodafone Germany CEO Dr Hannes Ametsreiter Joins Board of Technology Telco 1GLOBAL
-
Antiverse and GlobalBio, Inc. Extend Collaboration to Advance Antibody Cancer Therapeutics
-
LIBERTY GLOBAL ACQUIRES 100% OF TELENET FOLLOWING THE SIMPLIFIED SQUEEZE-OUT AND TELENET IS DELISTED ON 13 OCTOBER 2023
-
Demand for IT and Business Services in Europe Down in Q3, ISG Index™ Finds
-
Logitech Unveils Zone Wireless 2, the Ultimate AI-Powered Headset for Hybrid Work
-
Government of Monaco Adopts a VMware Sovereign Cloud to Enhance Data Security, Confidentiality and Digital Impact for the Principality, its Citizens, and Businesses
-
AM Best to Sponsor 2023 International Conference on Inclusive Insurance
-
SOTIO Further Expands Next-Generation ADC Platform with License to Synaffix’s ADC Technology
-
Gartner Digital Markets Releases 2024 Global Tech Trends Report at SaaStock Dublin
-
Deutsche Aircraft Selects Latecoere as Strategic Supplier of Doors for the D328eco™
-
Syngenta Sharpens Biologicals Focus With Launch of First Biologicals Service Center for Seed Treatment
-
EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023
-
TME Pharma Announces Publication of ESMO Congress 2023 Abstract on the Ongoing NOX-A12 GLORIA Phase 1/2 Trial in Glioblastoma
-
Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 – 24, 2023, Madrid, Spain
-
KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma
-
OSE Immunotherapeutics Presents First Positive Clinical Results With its anti-PD1 OSE-279 in Advanced Solid Tumors
-
Gilead Demonstrates the Impact of Global Collaboration in Advancing HIV Research and Health Equity at EACS 2023
-
ABIONYX Pharma RACERS Study in Sepsis Selected for Late-Breaking Clinical Results Poster Presentation at the American Society of Nephrology (ASN) 2023 Annual Meeting "Kidney Week"
-
Innate Pharma Announces Abstracts Selected for ESMO Congress 2023
-
10 Million Solar Panels Served Worldwide with APsystems MLPE Devices
-
Global Cybersecurity Leader eSentire Extends its Award-Winning 24/7 Security Operations Center as a Service (SOCaaS) Protection to Organizations Across the United Arab Emirates
-
T-Mobile US and Deutsche Telekom Global Carrier Complete Testing of World’s First 5G Standalone Roaming Program with AIS and Sunrise
-
Henry Schein Provides Information on Cybersecurity Incident
-
Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success
-
Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer
-
Six Measures Faraday Future Is Taking to Protect Stockholder Interests and a Review of 30 Company Achievements Since the End of 2022
-
MUST Connect 2023 Singapore highlighted the cutting-edge innovations of Korean life science startups
-
Digital Literacy Projects Define TDCX Foundation’s First Year
-
Novocure Announces Presence at European Society for Medical Oncology (ESMO) Congress 2023
-
CatalYm Presents Data at ESMO 2023 Expanding GDF-15’s Role in Checkpoint Therapy Resistance by Inhibition of Myeloid Immune Cell Activation
-
GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward
-
CORRECTING and REPLACING Creep It Simple: Rite Aid Releases DIY Halloween Costume Recipe Cards
-
HKTB Invites Visitors and Locals to "Hallo" Hong Kong Halloween
-
Ray Day, APR, Vice Chair of Stagwell, Elected 2025 PRSA Chair
-
Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
-
Metropolitan issues statement on Gov. Newsom signing bill to eliminate non-functional turf
-
Ankyra Therapeutics Presents Preliminary Phase 1 Canine Clinical Data Evaluating cANK-101 to Treat Advanced Malignant Melanoma in Dogs
-
New Phase 1 Dose Escalation Cohorts Data for Aulos Bioscience’s AU-007 Show Favorable Pharmacodynamic Effects at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeu
-
Verastem Oncology Announces Initial Results of RAMP 203 Trial of Avutometinib and LUMAKRAS™ (sotorasib) in KRAS G12C-Mutant Non-Small Cell Lung Cancer
-
Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecula
-
Rachel Smythe’s WEBTOON Sensation Lore Olympus Continues Awards Sweep with Third Consecutive Harvey Award Win for Digital Book of the Year
-
ARC® Fertility Leadership to Support ASRM Congress, October 14-18
-
Black Friday Samsung The Frame TV Deals (2023): Best Early Samsung QLED TV Sales Reported by Spending Lab
-
Economic Transformation Technologies is Excited to Announce Its Strategic Partnership with the Timmaron Group and the Appointment of Barbara D. Stinnett to their Advisory Board

